668 results on '"Azab, Abdel Kareem"'
Search Results
2. Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury
3. E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma
4. Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma
5. Synthesis, equilibrium, and biological study of a C-7 glucose boronic acid derivative as a potential candidate for boron neutron capture therapy
6. An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma
7. CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
8. Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy
9. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
10. Fatty acid binding proteins in multiple myeloma
11. A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma
12. Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia
13. Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors
14. Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma
15. Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma
16. The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma
17. Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
18. Biomaterials for cancer immunotherapy
19. List of contributors
20. Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy
21. Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy
22. Data from Hypoxia Promotes Dissemination and Colonization in New Bone Marrow Niches in Waldenström Macroglobulinemia
23. Supplementary Figure 2 from Hypoxia Promotes Dissemination and Colonization in New Bone Marrow Niches in Waldenström Macroglobulinemia
24. Supplementary Figure 1 from Hypoxia Promotes Dissemination and Colonization in New Bone Marrow Niches in Waldenström Macroglobulinemia
25. Supplementary Figure Legend from Hypoxia Promotes Dissemination and Colonization in New Bone Marrow Niches in Waldenström Macroglobulinemia
26. Supplementary Figure Legend from Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
27. Supplementary Figures S1-S3 from Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia
28. Supplementary Data from Src Tyrosine Kinase Regulates Adhesion and Chemotaxis in Waldenstrom Macroglobulinemia
29. Supplementary Figure 1 from Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
30. 3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma
31. Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia
32. Delivery systems for brachytherapy
33. CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma
34. A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma
35. IL-10R Inhibition Reprograms Tumor-Associated Macrophages and Reverses Drug Resistance in Multiple Myeloma
36. Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma
37. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy
38. LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas
39. Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
40. P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment
41. Defining the role of TORC1/2 in multiple myeloma
42. Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
43. Tumor-associated macrophages in multiple myeloma: advances in biology and therapy
44. A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma
45. microRNA-dependent modulation of histone acetylation in Waldenström macroglobulinemia
46. Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenström macroglobulinemia
47. Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia
48. Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy
49. RhoA and Rac1 GTPases play major and differential roles in stromal cell–derived factor-1–induced cell adhesion and chemotaxis in multiple myeloma
50. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.